Skip to main content

NovoSeven® RT (coagulation Factor VIIa, recombinant)

NovoSeven® RT (coagulation Factor VIIa, recombinant) is indicated for treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, Glanzmann’s thrombosthenia with refractoriness to platelets (with or without antibodies to platelets), and treatment of bleeding episodes and perioperative management in adults with acquired hemophilia.

The search will retrieve any scientific documents from the medical information database where the search terms match either the title or content of the document. The response(s) are not intended to offer recommendations for administering Novo Nordisk products in a manner inconsistent with approved labeling. To access the Prescribing Information for Novo Nordisk products, please click here.

Search for Letters

Find documents for this product by entering your search terms in the box below.

 

Text: double click to edit.

Have a Question?

Request information directly from the Novo Nordisk
Medical Information department.